Montelukast (MK-0476)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Montelukast (MK-0476), covering 2022-02-14 to 2022-02-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303) [Phase 3]